(Q43779982)

English

Antitumour activity of abiraterone acetate against metastatic castration-resistant prostate cancer progressing after docetaxel and enzalutamide (MDV3100).

scientific article published on 10 April 2013

Statements

Antitumour activity of abiraterone acetate against metastatic castration-resistant prostate cancer progressing after docetaxel and enzalutamide (MDV3100). (English)
10 April 2013
1807-1812

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit